The absence of tenascin-C in control tissue, deposition in asthma and proximity to MMP-1 expression denote tenascin-C as a potential, pathologically-relevant, regulator of MMP-1 expression in vivo and target for therapeutic intervention against airway remodelling. Here, MMP1 is linked to asthma.